Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -9.08x is 32% above its 5-year average of -13.34x, near the high end of its 5-year range (-230.58x–28.79x).
166.97% below its 12-month average of -3.40x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): 28.79x.
INTEREST COVERAGE RATIO
-9.08x
INTEREST COVERAGE RATIO AVG TTM
-3.40x
INTEREST COVERAGE RATIO AVG 3Y
-8.89x
INTEREST COVERAGE RATIO AVG 5Y
-13.34x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-166.97%
CURRENT VS 3Y AVG
-2.18%
CURRENT VS 5Y AVG
+31.92%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
-56.82%
vs the sector median at left
Celularity Inc.
Market Cap
$50.51M
Interest Coverage Ratio
-9.08x
TTM Avg
-3.40x
3Y Avg
-8.89x
5Y Avg
-13.34x
Market Cap
$50.18M
Interest Coverage Ratio
-145.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.99M
Interest Coverage Ratio
-13.25x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.33M
Interest Coverage Ratio
-14.01x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.13M
Interest Coverage Ratio
N/A
TTM Avg
254.37x
3Y Avg
222.37x
5Y Avg
222.37x
Market Cap
$50.48M
Interest Coverage Ratio
-6.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Celularity Inc. (CELU) | $50.51M | -9.08x | -3.40x | -8.89x | -13.34x |
| Clene Inc. (CLNN)vs › | $50.67M | -8.61x | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $50.18M | -145.74x | N/A | N/A | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $50.99M | -13.25x | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $51.33M | -14.01x | N/A | N/A | N/A |
| INmune Bio, Inc. (INMB)vs › | $50.38M | N/A | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | N/A | N/A | N/A | N/A |
| Microbot Medical Inc. (MBOT)vs › | $50.13M | N/A | 254.37x | 222.37x | 222.37x |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.48M | -6.14x | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $51.61M | 3.24x | 3.06x | 3.54x | 8.88x |
Interest Coverage
-9.1x
Debt/Equity
N/A
Current Ratio
0.09
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | 28.79x |
| 2025-12-31 | -24.59x |
| 2025-09-30 | -8.73x |
| 2025-06-30 | -8.16x |
| 2025-03-31 | -4.30x |
| 2024-12-31 | -5.12x |
| 2024-09-30 | -6.58x |
| 2024-06-30 | -6.56x |
| 2024-03-31 | -6.43x |
| 2023-12-31 | 20.08x |
| 2023-09-30 | -102.22x |
| 2023-06-30 | -38.47x |
| 2023-03-31 | -230.58x |
| 2021-12-31 | -19.70x |
| 2021-09-30 | 12.93x |
| 2021-06-30 | -74.19x |
| 2021-03-31 | -59.04x |
| 2020-12-31 | 15.27x |
| 2020-09-30 | -6.81x |
| 2019-09-30 | 0.12x |
| 2019-06-30 | 0.13x |
